Framework for the Supply of Radiopharmaceuticals and Related Consumables 2023

A Contract Award Notice
by HEALTHTRUST EUROPE LLP (HTE) ACTING ON BEHALF OF

Source
Contracts Finder
Type
Contract (Products)
Duration
4 year
Value
£100M
Sector
INDUSTRIAL
Published
12 Dec 2023
Delivery
01 Dec 2023 to 30 Nov 2027
Deadline
07 Jul 2023 11:00

Concepts

Location

Geochart for 1 buyers and 4 suppliers

1 buyer

4 suppliers

Description

HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases. The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.

Award Detail

1 Alliance Medical Radiopharmacy (Business Park Warwick)
  • Value: £100,000,000
2 GE Healthcare (Chalfont)
  • Value: £100,000,000
3 Curium Pharma (Portsmouth)
  • Value: £100,000,000
4 Xiel (Shepton Mallet)
  • Value: £100,000,000

CPV Codes

  • 09344000 - Radio-isotopes
  • 33000000 - Medical equipments, pharmaceuticals and personal care products
  • 33140000 - Medical consumables

Indicators

  • Contract is suitable for SMEs.

Reference

Domains